Biology Reference
In-Depth Information
68. Sato Y, Murase K, Kato J, Kobune M, Sato T, Kawano Y et al (2008) Resolution of liver
cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific
chaperone. Nat Biotechnol 26(4):431-442
69. Pirollo KF, Rait A, Zhou Q, Hwang SH, Dagata JA, Zon G et al (2007) Materializing the
potential of small interfering RNA via a tumor-targeting nanodelivery system. Cancer Res
67(7):2938-2943
70. Li SD, Chen YC, Hackett MJ, Huang L (2008) Tumor-targeted delivery of siRNA by self-
assembled nanoparticles. Mol Ther 16(1):163-169
71. Goldsmith M, Mizrahy S, Peer D (2011) Grand challenges in modulating the immune response
with RNAi nanomedicines. Nanomedicine (Lond) 6(10):1771-1785
72. Kortylewski M, Swiderski P, Herrmann A, Wang L, Kowolik C, Kujawski M et al (2009)
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitu-
mor immune responses. Nat Biotechnol 27(10):925-932
73. Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL et al (2008) T cell-specific siRNA
delivery suppresses HIV-1 infection in humanized mice. Cell 134(4):577-586
74. Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, Kumar P et al (2010) Targeted delivery
of siRNA to human dendritic cells to suppress Dengue viral infection and associated
proinflammatory cytokine production. J Virol 84(5):2490-2501
75. Shimaoka M, Takagi J, Springer TA (2002) Conformational regulation of integrin structure
and function. Annu Rev Biophys Biomol Struct 31:485-516
76. Cauli A, Yanni G, Pitzalis C, Challacombe S, Panayi GS (1995) Cytokine and adhesion mol-
ecule expression in the minor salivary glands of patients with Sjogren's syndrome and chronic
sialoadenitis. Ann Rheum Dis 54(3):209-215
77. Tanaka Y, Mine S, Figdor CG, Wake A, Hirano H, Tsukada J et al (1998) Constitutive
chemokine production results in activation of leukocyte function-associated antigen-1 on adult
T-cell leukemia cells. Blood 91(10):3909-3919
78. Peer D, Zhu P, Carman CV, Lieberman J, Shimaoka M (2007) Selective gene silencing in
activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated anti-
gen-1. Proc Natl Acad Sci USA 104(10):4095-4100
79. Elfakess R, Peer D (2010) Overcoming RNAi transduction in leukocytes using targeted and
stabilized nanoparticles. IDrugs 13(9):626-631
80. Peer D, Park EJ, Morishita Y, Carman CV, Shimaoka M (2008) Systemic leukocyte-directed
siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science 319(5863):
627-630
81. Kim SS, Peer D, Kumar P, Subramanya S, Wu H, Asthana D et al (2010) RNAi-mediated
CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol
Ther 18(2):370-376
82. Burnett JC, Rossi JJ (2012) RNA-based therapeutics: current progress and future prospects.
Chem Biol 19(1):60-71
Search WWH ::




Custom Search